Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning.

M B Young1, R Andero1,2, K J Ressler1,2,3

  • 1Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Translational Psychiatry
|September 16, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fine mapping of PTSD GWAS reveals a role for amygdala <i>Foxp2</i> in regulation of fear and threat responses.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Sex differences in fear memory consolidation via Tac2 signaling in mice.

Nature communications·2024
Same author

Development and validation of a brief screener for posttraumatic stress disorder risk in emergency medical settings.

General hospital psychiatry·2023
Same author

Childhood adversities and risk of posttraumatic stress disorder and major depression following a motor vehicle collision in adulthood.

Epidemiology and psychiatric sciences·2023
Same author

PACAP-PAC1R modulates fear extinction via the ventromedial hypothalamus.

Nature communications·2022
Same author

Prior differences in previous trauma exposure primarily drive the observed racial/ethnic differences in posttrauma depression and anxiety following a recent trauma.

Psychological medicine·2022
Same journal

Postpartum maternal bonding problems relate to aberrant neural processing of infant emotions: Results of an adapted fMRI emotional GoNoGo task.

Translational psychiatry·2026
Same journal

Ecological assessment of transdiagnostic clinical symptoms in serious mental illness with daily smartphone surveys.

Translational psychiatry·2026
Same journal

Microbiota-gut-brain axis in autism spectrum disorder: integrating brain structure, function, and transcriptomics.

Translational psychiatry·2026
Same journal

Neural mechanisms of fear memory precision and generalization: from auditory cortex to amygdala.

Translational psychiatry·2026
Same journal

Maraviroc attenuates inflammation-exacerbated cognitive and amyloid pathology in an early-stage Alzheimer's disease mouse model.

Translational psychiatry·2026
Same journal

High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?

Translational psychiatry·2026
See all related articles

3,4-methylenedioxymethamphetamine (MDMA) enhances fear extinction learning, a key process for treating post-traumatic stress disorder (PTSD). This effect is mediated by brain-derived neurotrophic factor (BDNF) signaling in the amygdala.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Behavioral Science

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA) shows promise for treating post-traumatic stress disorder (PTSD) when combined with psychotherapy.
  • Preclinical data are lacking to explain the mechanistic basis for MDMA's therapeutic effects on PTSD.
  • Fear extinction learning is crucial for exposure-based therapies and may be a target for MDMA.

Purpose of the Study:

  • To investigate whether MDMA enhances fear extinction learning.
  • To explore the neurobiological mechanisms underlying MDMA's effects on fear extinction.
  • To determine if MDMA could be a valuable adjunct therapy for PTSD and anxiety disorders.

Main Methods:

  • Mice underwent cued fear conditioning, followed by MDMA or vehicle administration before extinction training.

Related Experiment Videos

  • MDMA was administered systemically and directly into the basolateral amygdala (BLA).
  • Behavioral extinction, Fos, and brain-derived neurotrophic factor (Bdnf) mRNA levels were measured.

    • Main Results:

    • MDMA (7.8 mg/kg) significantly enhanced long-term fear extinction.
    • MDMA increased Fos expression in the amygdala and medial prefrontal cortex (mPFC).
    • MDMA increased amygdala Bdnf expression, and this enhancement was BLA-dependent and BDNF signaling-dependent.

    Conclusions:

    • MDMA enhances fear memory extinction via a BDNF-dependent mechanism.
    • MDMA's action involves the amygdala and medial prefrontal cortex.
    • MDMA may serve as an effective adjunct therapy for PTSD and related anxiety disorders.